Tag: txa

February 2021 podcast

February 2021 Round Up Podcast. St Emlyn’s

Our regular podcast round up from February 2021. Iain and Simon highlight the key learning points from this month on the St Emlyn’s blog and podcast. Please remember to subscribe to the podcast on iTunes/Google

NoPAC study

JC: The NoPAC trial. TXA does not work for epistaxis. St Emlyn’s

Over the years we have had more than a passing interest in tranexamic acid. In part because we have been involved in some of the research, recruiting to trials, or acting as principal investigators, but

JC: Should we rubber STAAMP prehospital TXA?

This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma, one argument has just been

September Round Up Podcast

Welcome to our audio round up of everything on the blog during September. It’s been a relatively quiet on the blog post this month, but we chat through not only blogposts on the REMAP-CAP trial,

JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s

Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also be using it in mild/moderate

JC: TXA in severe head injury. St Emlyn’s

Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence was not entirely definitive, but

JC: Halt! It’s not time for TXA! Or is it? HALT-IT results at St Emlyn’s

If you’re any kind of emergency care aficionado, you probably worship at the altar of tranexamic acid (TXA). With data showing more favourable outcomes from its use in traumatic bleeding​(1)​, post-partum haemorrhage​(2)​, maybe traumatic brain

CRASH-3

JC: Tranexamic Acid (TXA) in Head Injury. The CRASH-3 results. St Emlyn’s

St Emlyn’s had sight of a pre-publication copy of the CRASH-3 trial from the trial team. This allowed us to prepare this blog in advance of publication. The trial authors have not been involved in

JC: Does earlier TXA save lives? St.Emlyn’s

Administration of tranexamic acid (TXA) is integral part of the management for major trauma patients in the UK. It is deemed such an important aspect that its administration is used as a quality indicator to

JC: Tranexamic acid – does the evidence stack up?

Here at St.Emlyn’s we are big fans of Tranexamic Acid in trauma. We believe that it makes a difference to overall mortality in patients likely to be bleeding and also that there is some evidence